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Abstract
Introduction
Macular degeneration (MD) can cause a central visual field defect. In a previous study, we
found volumetric reductions along the entire visual pathways of MD patients, possibly indi-
cating degeneration of inactive neuronal tissue. This may have important implications. In
particular, new therapeutic strategies to restore retinal function rely on intact visual path-
ways and cortex to reestablish visual function. Here we reanalyze the data of our previous
study using surface-based morphometry (SBM) rather than voxel-based morphometry
(VBM). This can help determine the robustness of the findings and will lead to a better
understanding of the nature of neuroanatomical changes associated with MD.
Methods
The metrics of interest were acquired by performing SBM analysis on T1-weighted MRI
data acquired from 113 subjects: patients with juvenile MD (JMD; n = 34), patients with age-
related MD (AMD; n = 24) and healthy age-matched controls (HC; n = 55).
Results
Relative to age-matched controls, JMD patients showed a thinner cortex, a smaller cortical
surface area and a lower grey matter volume in V1 and V2, while AMD patients showed thin-
ning of the cortex in V2. Neither patient group showed a significant difference in mean cur-
vature of the visual cortex.
Discussion
The thinner cortex, smaller surface area and lower grey matter volume in the visual cortex
of JMD patients are consistent with our previous results showing a volumetric reduction in
their visual cortex. Finding comparable results using two rather different analysis
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techniques suggests the presence of marked cortical degeneration in the JMD patients. In
the AMD patients, we found a thinner cortex in V2 but not in V1. In contrast to our previous
VBM analysis, SBM revealed no volumetric reductions of the visual cortex. This suggests
that the cortical changes in AMD patients are relatively subtle, as they apparently can be
missed by one of the methods.
Introduction
Macular degeneration (MD) is a group of retinal diseases which can cause a central visual field
defect, due to damage in the macular region. In a previous neuro-imaging study, voxel-based
morphometry (VBM) analysis showed volumetric changes in the visual cortex of MD patients
with binocular central visual field defects, compared to healthy controls[1]. The goal of the cur-
rent study was to further characterize these volumetric changes in the same group of MD
patients using surface- rather than voxel-based metrics of brain morphology. Surface-based
morphometry (SBM) can provide additional information about the brain structure such as cor-
tical thickness, curvature and surface area.[2] Hence, analyses using SBMmay provide further
insight into the nature of the neuroanatomical changes previously found in MD patients. This
is important, as such structural changes might limit future treatments of MD that aim to
restore visual function, such as retinal implants, stem-cell treatment and retinal pigment epi-
thelium transplantation.[3,4]
MD can be divided into age-related macular degeneration (AMD) and juvenile macular
degeneration (JMD). In AMD, the macula degenerates by the accumulation of drusen in the
macular area, which in turn interferes with the retinal metabolism. The degeneration of the
macula can cause a central visual field defect.[5–7] Worldwide, AMD is the third most preva-
lent cause of blindness (8.7%).[8] However, in diverse parts of the world, the prevalence of
AMD as a cause of visual impairment or blindness varies. [9–13] JMD is a group of diverse eye
diseases, which includes Stargardt’s disease, Best’s vitelliform retinal dystrophy (Best’s disease),
cone-rod dystrophy, and central areolar choroidal dystrophy. These diseases start in the early
decades of life and are mostly hereditary. The different pathological mechanisms of these dis-
eases all lead to the loss of photoreceptors, and therefore cause a central visual field defect.
If the visual field defect in MD occurs in both eyes and overlaps–which is common–the
activity in specific parts along the visual pathways is reduced, potentially causing functional
deprivation. This deprivation may be responsible for the structural changes in the visual path-
ways. Alternatively, changes may be caused by anterograde transsynaptic degeneration, in
which damage of the retinal ganglion cells transmits to related neurons, resulting in axonal
damage of the visual pathways.
In both AMD and JMD patients, previous studies have found a reduction of the grey matter
volume near the occipital pole in the posterior part of the calcarine sulcus.[14,15] This indi-
cates that MD is associated with retinotopic-specific neuronal degeneration of the visual cortex,
as the central visual field is projected at the occipital pole. In addition to a decreased grey mat-
ter volume, a recent study from our group also showed a decreased white matter volume along
the visual pathways in both AMD and JMD patients. Additionally, in AMD, a decreased white
matter volume was found outside the visual pathways, particularly in the frontal lobe.[1]
The goal of the current study was to further characterize the previously reported volumetric
changes in the visual cortex in MD patients. To do so, we applied SBM to the same group of
AMD and JMD patients in which we previously applied VBM and demonstrated changes in
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grey and white matter volume.[1] Using the surface-based analysis package Freesurfer, we
investigated whether these volumetric differences are also reflected in changes in the cortical
thickness, mean curvature or cortical surface area of the MD patients compared to age-
matched controls. Moreover, we also reassessed grey matter volume using this surface-based
approach. Recently, SBM showed a decreased gyrification in albinism in the same areas where
VBM had indicated a decreased grey matter volume.[16] Therefore, we hypothesized to find a
decreased gyrification in addition to a reduced volume in the visual cortex of MD patients as
well.
Methods
Ethics statement
This study conformed to the principles of the Declaration of Helsinki, and was approved by the
respective medical review board of each centre participating in the study: the Medical Ethical
committee of the University Medical Center Groningen in Groningen; the York Neuroimaging
Centre Ethics committee and the local National Health Service Ethics committee in York; the
Royal Holloway Ethics committee of the University of London and the local National Health
Service ethics committee in London; and the Ethical committee of the University of Regens-
burg in Regensburg. All participants gave written informed consent before participating in the
study. Written informed consent from the children enrolled in the study were obtained from
both the child and from the respective parent.
Subjects
For this study, we included 113 subjects, which comprises the same group of subjects that was
included in the study of Hernowo et al.[1] These subjects were recruited in Groningen (the
Netherlands), York and London (United Kingdom) and Regensburg (Germany). Patients were
included in this study when they suffered from a binocular visual field defect due to MD.
Healthy control subjects had a good visual acuity in both eyes, and were free from visual field
defects. All subjects were free from neurological or psychiatric disorders.
Here, we will briefly specify the subjects characteristics. For the more complete description
of our subjects, we refer to Hernowo et al.[1] We included 34 JMD patients, 24 AMD patients
and 55 healthy control subjects. The patients were assigned to either the JMD or the AMD
group based on their clinical diagnosis. We split the group of healthy controls into 33 controls
for the JMD patients and 22 controls for the AMD patients, based on their age. This makes
four subject groups for the analyses: 1) JMD patients, 2) young healthy controls (HCY), age-
matched to the JMD patients, 3) AMD patients, and 4) old healthy controls (HCO), age-
matched to the AMD patients. JMD patients had a mean age of 40.2 years (range 12–66 years),
the HCY subjects had a mean age of 37.4 years (range 13–60 years). AMD patients had a mean
age of 75.2 years (52–91 years), the HCO subjects had a mean age of 68 years(61–83 years).
Table 1 shows the mean scotoma diameter for the AMD and JMD patients and the mean dis-
ease duration for the AMD and JMD patients from Regensburg.
Data acquisition
Magnetic resonance images (MRI) were acquired using three different scanners in three cen-
ters. However, all acquisitions were of 1 mm x 1 mm x 1 mm resolution. Information on the
MRI acquisition has also been described in the previous publication of Hernowo et al.[1]
Groningen: the dataset was obtained using an 8-channel phased-array SENSE head coil on a
3.0 Tesla Philips Intera (Eindhoven, The Netherlands) at the Neuroimaging Center, University
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of Groningen, University Medical Center Groningen. Three-dimensional structural images
were acquired using a sequence T1W/3D/TFE-2, 8° flip angle, repetition time (TR) 8.70 ms,
echo time (TE) 4.4 ms, matrix size 256 x 256, field of view 230 x 160 x 180, yielding 160 slices.
York: the dataset was obtained using an 8-channel, phased-array head coil on a Siemens
Trio 3 Tesla at the Combined Universities Brain Imaging Center, Royal Holloway University of
London. Multi-average, whole head T1-weighted anatomical images were acquired using an
MDEFT sequence with 16° flip angle, TR 7.90 ms, TE 2.5 ms, matrix size 256 x 256, field of
view 176 x 256 x 256, yielding 176 sagittal slices.
Regensburg: the dataset was obtained using a multicoil phased-array head coil on a 3.0
Tesla Allegra Scanner (Siemens, Erlangen, Germany). Whole brain T1-weighted images were
obtained using a 3D-MPRAGE sequence, matrix size 256 x 256, field of view of 256 x 256 x
160, yielding 160 slices, using the Alzheimer’s Disease Neuroimaging Initiative (ADNI)
sequence (TR = 8.79 ms, TE = 2.6 ms, flip angle 9°).[17]
Surface-based morphometry
SBM analyses of cortical thickness, mean curvature, surface area and grey matter volume were
performed using the Freesurfer image analysis suite (version 5.3.0, available at: http://surfer.
nmr.mgh.harvard.edu/). The processing includes removal of non-brain tissue,[18] automated
Talairach transformation, intensity normalization,[19] tessellation of the grey/white and grey/
cerebrospinal fluid boundaries and automatic correction of topologic inaccuracies,[20,21] sur-
face deformation and inflation,[22,23] registration to a spherical atlas[24] and automatic par-
cellation of the cortex surface based on gyral and sulcal structures.[25,26] The reconstruction
process resulted in of a variety of surface-based data, such as cortical thickness, mean curva-
ture, surface area measurement and grey matter volume.
Data analysis
We performed both whole brain and region-of-interest (ROI) -based analyses. In the whole
brain analyses, we analyzed the cortical thickness and the mean curvature. We studied differ-
ences in cortical thickness and mean curvature, and differences in the correlation between age
and cortical thickness and the correlation between age and mean curvature between patients
and their age-matched controls. To correct for any sources of variance exclusively related to
age or scanner location, we added age and scanner location at which the subject was scanned as
covariates to this analysis. To correct for multiple comparisons, we applied a false-discovery
rate (FDR) value of 0.05.
Table 1. Patient characteristics.
Characteristics Values
AMD JMD
Number of subjects 24 34
Scotoma diameter, mean (range), degree 14 (4–25) 20 (3–65)
Subjects from Regensburg
Number of subjects 8 26
Disease duration, mean (range), years 7.6 (1–21) 15.9 (2–42)
Scotoma diameter in degrees of visual angle; mean duration of the disease in the subjects from
Regensburg. JMD—juvenile macular degeneration; AMD—age-related macular degeneration.
doi:10.1371/journal.pone.0146684.t001
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Cortical thickness was calculated as the shortest distance between the grey/white boundary
and the grey/cerebrospinal fluid boundary at each vertex across the cortex in millimeters
(mm). Mean curvature was calculated as the mean of the minimum and maximum bending of
the surface in each vertex in mm-1. Surface area was measured by calculating the surface area
size of each triangle, in which the surface was divided by connecting the vertices, in mm2. The
surface area of a single triangle depends on the number of vertices the cortex was divided into,
which in turn depends on the size of the brain. Since it is not yet clear whether this would
reflect the actual surface area in whole brain analysis, we decided not to perform whole brain
analysis on surface area. Grey matter volume was calculated as the product of the surface area
and cortical thickness in mm3, therefore we did also not perform a whole brain analyses on
grey matter volume.
For the ROI-analyses we examined the surface area and grey matter volume, as well as the
cortical thickness and mean curvature. We defined our ROIs using the Freesurfer labels for the
areas V1 and V2. Moreover, we consecutively divided both V1 and V2 in an anterior and a pos-
terior part. We chose to analyze the anterior and posterior parts of V1 and V2 separately
because all patients had a central visual field defect. Since the central visual field is retinotopi-
cally represented in the occipital pole, we expected the anterior and posterior parts of V1 and
V2 not to be equally affected. Therefore, an analysis of the entire V1 and V2 might not present
sufficient details on the actual structural changes in our patient groups. Fig 1 depicts the
defined ROIs on the left hemisphere of the average brain; the actual analyses were done on the
ROIs in both hemispheres combined.
For each ROI, data on cortical thickness, mean curvature, surface area and grey matter vol-
ume were extracted using Freesurfer. Differences between patients and controls in the specific
ROIs were examined using MANCOVA. The dependent variables were cortical thickness,
mean curvature, surface area and grey matter, and the subject groups were entered as a fixed
factor. Also in this analysis, age and scanner location were added as covariates.
Specifically in patients from Regensburg, data on disease duration was available. In this sub-
group of patients, we analyzed whether there was a correlation between disease duration and
cortical thickness, mean curvature, surface area and grey matter for each ROI. We tested this
using the Pearson correlation test. Statistical tests were performed in the IBM SPSS Statistics
software package, version 20.
Results
ROI-based analysis
Within the V1 anterior, V1 posterior, V1 anterior and V2 posterior ROIs, we performed analy-
ses of the cortical thickness, mean curvature, surface area and grey matter volume. Fig 2 shows
the mean values of the anatomical features for all four groups: the JMD patients, the younger
healthy controls, the AMD patients and the older healthy controls. Table 2 presents more
details on these values and highlights which features differed significantly between patients and
controls in the individual ROIs.
In JMD patients, we found a thinner cortex in V1 posterior and V2 posterior, a smaller sur-
face area in V1 anterior, V1 posterior and V2 posterior and a lower grey matter volume in V1
posterior, V2 anterior and V2 posterior compared to age-matched healthy controls (p<0.05).
No differences were found in mean curvature measurements.
In AMD patients, we found a thinner cortex in V2 anterior and V2 posterior compared to
age-matched healthy controls (p<0.05). We did not find differences in mean curvature, surface
area size and grey matter volume.
Anatomical Properties of the Visual Cortex in Macular Degeneration
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Furthermore, we tested whether disease duration was correlated with cortical thickness,
mean curvature, surface area or grey matter volume in the defined ROIs. Since data on disease
duration was only available from patients from Regensburg, we performed these analyses only
in these subgroups. In both JMD and AMD patients we found no significant correlation
between disease duration and any of the parameters in the ROIs.
Whole brain analysis
We performed SBM analyses of the cortical thickness and mean curvature in the whole brain
in the JMD and in the AMD group, both compared to their age-matched healthy control
group. Compared to the healthy controls, we found no significant difference (applying an FDR
value of 0.05) neither for the JMD nor for the AMD patient group. Furthermore, we analyzed
the correlation between age and cortical thickness and the correlation between age and mean
curvature in the whole brain in the JMD and the AMD group, compared to their age-matched
control group. Also in this analysis, we found no significant differences (applying an FDR
value of 0.05) for neither the JMD nor the AMD patients.
Fig 1. ROIs in the visual cortex. ROIs are depicted on the left hemisphere. Red–V1 anterior; Cyan–V1 posterior; Dark blue–V2 anterior; Magenta–V2
posterior. ROI–region of interest.
doi:10.1371/journal.pone.0146684.g001
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Discussion
To our knowledge, this is the first study that reports the results of a SBM analysis of the visual
cortex of MD patients. The association of MD– a common cause of blindness world-wide–with
structural changes in the brain has only recently become clear.[1,14,15,27–32] Previous studies
have reported volumetric reductions of grey and white matter along the entire visual pathways
Fig 2. ROI morphometric values. Average cortical thickness, mean curvature, surface area and grey matter volume in the ROIs V1 anterior, V1 posterior,
V2 anterior and V2 posterior. The bars show the mean value of the specific metric of the ROI in the particular group. The error bars show ±1 standard errors of
the mean. p-values are given. ROI—region of interest; JMD—juvenile macular degeneration; HCY—healthy controls young (age-matched to JMD); AMD—
age-related macular degeneration; HCO—healthy controls old (age-matched to AMD). * Significant difference between the patients group and the respective
age-matched control group (p < 0.05).
doi:10.1371/journal.pone.0146684.g002
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of MD patients.[1,14,15] Here, we used a surface-based approach to examine several additional
anatomical features of the visual cortex in MD, such as cortical thickness, mean curvature and
surface area. This SBM analysis further characterizes the previously reported volumetric
changes in the visual cortex of MD patients.
ROI-based analysis confirms the presence of structural changes in JMD
patients
In the JMD patients, compared to age-matched controls, we found a smaller cortical thickness
in V1 posterior and V2 posterior, a smaller surface area in V1 anterior, V1 posterior and V2
Table 2. ROI morphometric values (μ ± σμ).
JMD HCY f-value
(df = 1.63)
p-value AMD HCO f-value
(df = 1.42)
p-value
Average
cortical
thickness
(mm)
V1
anterior
1.653 ± 0.036 1.682 ± 0.037 0.029 0.866 1.527 ± 0.033 1.594 ± 0.042 3.447 0.070
V1
posterior
1.775 ± 0.024 1.851 ± 0.031 4.227 0.044 * 1.756 ± 0.041 1.832 ± 0.034 2.700 0.108
V2
anterior
1.965 ± 0.035 2.029 ± 0.029 1.834 0.181 1.804 ± 0.022 1.865 ± 0.035 4.078 0.050 *
V2
posterior
1.888 ± 0.021 1.991 ± 0.023 11.400 0.001 * 1.809 ± 0.028 1.929 ± 0.028 8.351 0.006 *
Mean
Curvature
(mm-1)
V1
anterior
0.162 ± 0.003 0.168 ± 0.003 2.500 0.119 0.179 ± 0.003 0.184 ± 0.009 3.297 0.077
V1
posterior
0.186 ± 0.002 0.185 ± 0.002 0.002 0.963 0.188 ± 0.005 0.194 ± 0.007 1.947 0.170
V2
anterior
0.170 ± 0.002 0.173 ± 0.002 1.323 0.254 0.173 ± 0.002 0.174 ± 0.003 1.282 0.264
V2
posterior
0.181 ± 0.002 0.179 ± 0.001 0.696 0.407 0.181 ± 0.004 0.186 ± 0.005 1.495 0.234
Surface area
(mm2)
V1
anterior
2130.29 ± 74.94 2352.67 ± 81.51 4.145 0.046 * 2185.38 ± 90.65 2060.50 ± 95.69 3.607 0.064
V1
posterior
4753.91 ± 123.91 5256.55 ± 149.70 6.598 0.013 * 4408.08 ± 169.35 4770.41 ± 212.15 0.160 0.691
V2
anterior
4203.88 ± 124.91 4502.91 ± 104.34 3.225 0.077 4189.17 ± 162.17 4037.82 ± 153.63 3.190 0.081
V2
posterior
7998.18 ± 151.94 8613.58 ± 204.26 5.718 0.020 * 7688.42 ± 252.08 7795.09 ± 273.75 0.231 0.633
Grey matter
volume (mm3)
V1
anterior
3590.97± 138.45 4035.21 ± 166.09 3.516 0.065 3455.33 ± 140.77 3391.14 ± 192.45 0.381 0.540
V1
posterior
9682.56 ± 229.84 11068.33 ± 311.69 11.898 0.001 * 8931.46 ± 312.43 10024.64 ± 347.80 2.205 0.145
V2
anterior
8764.59 ± 280.49 9750.70 ± 272.10 5.890 0.018 * 8117.08 ± 266.15 8053.18 ± 349.58 0.269 0.607
V2
posterior
17325.68 ± 331.33 19448.18 ± 485.69 12.028 0.001 * 16031.33 ± 446.11 17215.18 ± 564.76 0.811 0.373
Average cortical thickness, mean curvature, surface area and grey matter volume were extracted from the ROIs V1 anterior, V1 posterior, V2 anterior and
V2 posterior. Mean values and standard error of the mean are presented for each parameter and each ROI (f-values, degrees of freedom and p-values
are given).
ROI—region of interest; μ - mean; σμ - standard error of the mean; df–degrees of freedom; JMD—juvenile macular degeneration; HCY—healthy controls
young (age-matched to JMD); AMD—age-related macular degeneration; HCO—healthy controls old (age-matched to AMD).
* Signiﬁcant difference between the patients group and the respective age-matched control group (p < 0.05).
doi:10.1371/journal.pone.0146684.t002
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posterior, and lower grey matter volume in V1 posterior, V2 anterior and V2 posterior. We
found no differences in mean curvature.
The majority of the changes were found in the posterior region of the visual cortex, where
central vision is represented. This is in agreement with the notion that the central visual field
defects may cause–through a loss of activity in the visual pathways–the structural changes.
However, the surface area was also reduced in V1 anterior and the grey matter volume was also
reduced in V2 anterior. In V2 anterior, the cortical thickness and the surface area were also
lower in the JMD patients than in the healthy controls, but these findings did not reach signifi-
cance (p = 0.181 for cortical thickness; p = 0.077 for surface area). These thinner cortex and
smaller surface area, albeit not significant, can together explain the significant changes in grey
matter volume in V2 anterior. This suggests that not all structural changes have a direct bearing
on retinotopic-specific deprivation. Possibly, spontaneous oscillatory spike bursts of the retinal
ganglion cells could partly explain these results. Such spontaneous activity has been reported in
retinal degeneration mice and rats.[33–35] Furthermore, MD patients have to rely on their
peripheral visual field for their daily tasks. This means that the peripheral visual field has a dif-
ferent function in MD patients than healthy controls. However, previous fMRI studies have
shown conflicting results on whether functional changes in the visual cortex appear in MD
patients.[27,32,36–39] Nevertheless, even if functional changes do not appear in MD, the
changed usage of the peripheral visual field might form an additional explanation for the ana-
tomical changes in the anterior V1 and V2. Together, these findings in the ROI analyses show
that our previously reported volumetric reductions of grey matter in the visual cortex of JMD
patients are associated with a thinner cortex and a smaller surface area, but not with alterations
in the mean cortical curvature.
Partial confirmation of reduced cortical thickness in AMD patients
In AMD patients, compared to age-matched controls, only cortical thickness in V2 anterior
and V2 posterior was reduced. In contrast, in our previous VBM study, in the AMD patients,
we found more widespread volumetric reductions of the grey matter in cortical regions includ-
ing primary visual cortex. The fact that changes in cortical thickness were found in both V2
anterior and V2 posterior suggests that these may not have a direct bearing on a retinotopic-
specific deprivation. However, also in AMD the previously suggested possibility of spontaneous
activity of the retinal ganglion cells and the different function of the peripheral visual field
might influence these anatomical changes.[27,32–39] Additionally, the observed neuroanatom-
ical changes in MDmight not only be explained by functional deprivation due to the visual
field defect, but also to associated neurodegenerative processes. Specifically, a previously
described association between AMD and Alzheimer’s disease might play a role in the neuroan-
atomical changes.[40–43]
More widespread structural degeneration in the visual cortex of JMD
compared to AMD patients
In the JMD patients we found more widespread cortical thinning, reduction of surface area and
volume than in the AMD patients. This could be explained by the fact that–on average–the
JMD patients in our study had larger visual field defects and a poorer visual acuity than the
AMD patients. As a result, visual deprivation will have been more severe in the JMD patients
too. If cortical structural degeneration is related to visual deprivation, AMD patients would be
expected to show less extensive reductions than the JMD patients, as indeed we find here.
Additionally, due to the ageing of their brains, also the healthy older subjects might show more
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variability in cortical structure, which can make it more difficult to demonstrate disease-related
changes in AMD patients.
No evidence for a changed cortical gyrification pattern in MD patients
Based on Bridge et al., [16] who reported a decreased gyrification in albinism in an area where
VBM showed decreased grey matter volume, we expected to find a similar decrease in gyrifica-
tion also in our group of MD patients in the occipital pole–the area where previously grey mat-
ter volumetric reductions were found. However, in our patients, mean curvature is the only
measurement that did not show any differences in either of the patient groups, compared to
their age-matched healthy controls. This suggests that the cause of cortical degeneration in MD
and albinism may be rather different in nature, which may be related to the fact that albinism
is a congenital disease, whereas MD develops later in life.
Whole-brain analysis reveals no structural changes outside of visual
cortex
To explore the further presence of anatomical changes, we also performed an exploratory
whole brain SBM analysis. We were keen on performing these analyses, because morphological
differences might also be present outside of the visual cortex. Specifically, our previous VBM
analysis had indicated the presence of white matter volumetric reductions in the frontal lobe in
the AMD patients.[1] However, compared to their respective age-matched controls, in neither
the JMD nor the AMD patients we found differences in cortical thickness or in mean curvature.
As mentioned above, such differences were revealed in the ROI-based SBM analyses in V1 and
V2, and they were also more evident in the JMD patients than in the AMD patients. These dif-
ferences between the results of whole-brain and ROI-analysis can be explained by the fact that
the threshold for finding differences in whole-brain analysis was higher than in ROI analysis.
The higher threshold in whole brain analysis was due to the correction for multiple compari-
sons, which is necessary when analysing such amounts of data points. In ROI-analysis it is not
necessary to apply correction, since the amount of comparisons is much lower and the specific
ROIs were selected based on the likelihood of finding differences based on previous studies
Comparison of SBM- and VBM-analyses
The surface-based approach that we used here indicates a number of structural changes that
are consistent between our present SBM and our previous VBM study, particularly in the JMD
patients. However, not all SBM results corroborate the VBM results. Part of the difference may
be due to the use of different methodology. SBM applies a different method for segmenting the
brain, and also for the calculation of the grey matter volume than VBM. Therefore, the border
between grey matter and white matter and the cerebrospinal fluid is defined differently in each
method. Consequently, the grey matter volume measurements can also be different. On the
one hand, finding changes using such different approaches establishes their robustness. On the
other hand, if one of the techniques is more sensitive than the other, subtle cortical changes
could simply be missed by one of the methods. SBMmight give a more accurate representation
of structural differences because it takes the highly folded nature of the cortex into account,
which is not the case in VBM analysis. This could also explain some of the discrepancies
between the results of our two studies. Likewise, previous studies in a variety of neurological
and ophthalmological disorders also applied both types of analyses, and also found some differ-
ences in their results in surface-based analyses compared to voxel-wise analysis. SBM does not
always find changes in cortical features in areas where VBM found differences in grey matter
volume.[16,44–47] The opposite occurs as well: in some studies SBM revealed changes in
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cortical features in areas where VBM did not uncover volumetric differences.[16,47,48] A limi-
tation of SBM is that at present it is only able to uncover changes in grey matter.
Limitations
In our present study, the ROI definitions of V1 and V2 were not based on a retinotopic exami-
nation in the individual subjects, but on average brain templates, included in Freesurfer. In the
individual subjects, this may cause a deviation of the borders of these ROIs from their actual
ones, which may have affected our results in the ROI-analysis.
In this study, we combined structural MRI data from three different centers. The different
MRI-scanners and setting at each location could potentially have an effect on analyses of the
cortical properties. However, there are two reasons that we can exclude such effects. First, we
avoid systematic influences of differences in scanner properties by including scanner location
as a covariate in all of our analyses. Second, both patients and controls were scanned in all
three scanners. An important advantage of combining the data is the large groups of patients
and controls that are obtained in this way, which increases study power and allows drawing
more robust conclusions.
From the analyses in the JMD patients, we can conclude that in the diseases that we investi-
gated, the presence of a central visual field defect at a young age of onset, is associated with
neuro-anatomical changes. However, it is not possible to determine whether such neuro-ana-
tomical changes occur in the separate diseases from the present analyses. We included diseases
of different entity in the JMD group for several reasons. First, patients with the different dis-
eases included in the JMD group form small groups separately, from which we would not be
able to draw strong conclusions. Second, although the etiology of the separate diseases is differ-
ent, they have in common the development of a central visual field defect and the age of onset
in the first decades of life. Therefore, we are able to draw robust conclusion from these analyses
about the association between a central visual field defect which develops in the first decades of
life and changes in the brain.
Future research
A strength of the present study is that we re-examined the same group of subjects with SBM
as Hernowo et al.[1] did with VBM. Therefore, we were able to compare the outcomes of
these two methods, determine the robustness of the structural brain changes in MD, and
unravel more details regarding the nature of the previously found volumetric changes. It
would be interesting to use both of these methods in the future in a new group of patients,
preferably in a longitudinal study. With such a study design it would be possible to track
changes in specific anatomical features in individual patients over time, and more precisely
determine the relationship between disease progression and severity of the degeneration. In
turn, this could guide future research into therapies for MD, which might have to expand
their focus from exclusive ocular treatment to combining eye treatment with treatment of
neurodegeneration.
With 3T MRI images and the current methods of segmentation of the brain it is possible to
examine differences in neuroanatomical properties. However, it is not possible to specify
whether changes in the cortex are supragranular, granular or infragranular, which would be
particularly interesting for a better understanding of the pathogenesis of the brain changes. In
the future, it might be possible to perform such analyses of the cortical layers, with 7T and
super-high resolution (9T) MRI scanning. However, it will take some years before these tech-
niques can be applied in large groups of patients, as we did in the present study.
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Summary
In summary, using SBM, we found changes in several anatomical properties in the visual cortex
of both JMD and AMD patients, compared to healthy age-matched controls. JMD patients
showed a thinner cortex, smaller surface area and lower grey matter volume in V1 and V2.
AMD patients showed a thinner cortex in V2 only. These different findings in JMD and AMD
patients may be related to the larger visual field defect and poorer visual acuity in JMD patients
compared to AMD patients. Adding to our previous VBM study in the same group of subjects,
these results confirm the cortical degeneration in MD patients and indicate that the chance for
successful therapeutic restoration of functional vision reduces with disease progression.
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